Form 4: TriSalus Life Sciences Executive Sells Shares
Insider Transaction (Form 4)
Richard Marshak, Chief Commercial Officer of TriSalus Life Sciences, Inc., sold 325 shares of common stock on October 5, 2026 for $4.39 per share.
Summary
- Open-market sale: disposed of 325 Common Stock at $4.39 ($1,427) on October 5, 2026; holds 127,994 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $1,427 of stock on the open market.
Insider Transactions
Richard Marshak — Officer (Chief Commercial Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-05 | Open-market sale | Common Stock | 325 | $4 | $1.4K | 127,994 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-05 | Open-market sale (325 shares) |
Keywords
insider transaction, Form 4, TLSI, TriSalus Life Sciences, Inc., bearish, Richard Marshak
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.